Chemoenzymatic synthesis of bridged homolyxofuranosyl pyrimidine nucleosides: Bicyclic AZT analogues. 2023

Harbansh Singla, and Sandeep Kumar, and Kavita, and Jyotirmoy Maity, and Ashok K Prasad
Bioorganic Laboratory, Department of Chemistry, University of Delhi, Delhi, 110 007, India.

A greener chemo-enzymatic methodology has been developed for the synthesis of conformationally restricted diastereomeric homolyxofuranosyl pyrimidines (AZT analogue), i.e., (5'R)-3'-azido-3'-deoxy-2'-O,5'-C-bridged-β-d-homolyxofuranosyl-uracil and thymine starting from inexpensive diacetone-d-glucofuranose in 18% and 21% overall yields, respectively. In one of the key steps in multistep synthesis of bicyclic AZT analogues, the primary hydroxyl group of 3'-azido-3'-deoxy-β-d-glucofuranosyl pyrimidines has been acetylated using Novozyme® 435 in THF in 92% and 97% yields, respectively. The monoacetylated nucleoside was converted to desired bicyclic AZT analogue in two steps in an overall yield of 82% and 83%, respectively.

UI MeSH Term Description Entries
D009705 Nucleosides Purine or pyrimidine bases attached to a ribose or deoxyribose. (From King & Stansfield, A Dictionary of Genetics, 4th ed) Nucleoside,Nucleoside Analog,Nucleoside Analogs,Analog, Nucleoside,Analogs, Nucleoside
D011741 Pyrimidine Nucleosides Pyrimidines with a RIBOSE attached that can be phosphorylated to PYRIMIDINE NUCLEOTIDES. Nucleosides, Pyrimidine
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D013941 Thymine One of four constituent bases of DNA. 5-Methyluracil,5 Methyluracil
D014498 Uracil One of four nucleotide bases in the nucleic acid RNA.

Related Publications

Harbansh Singla, and Sandeep Kumar, and Kavita, and Jyotirmoy Maity, and Ashok K Prasad
January 2022, Beilstein journal of organic chemistry,
Harbansh Singla, and Sandeep Kumar, and Kavita, and Jyotirmoy Maity, and Ashok K Prasad
August 2001, The Journal of organic chemistry,
Harbansh Singla, and Sandeep Kumar, and Kavita, and Jyotirmoy Maity, and Ashok K Prasad
December 1972, The Journal of organic chemistry,
Harbansh Singla, and Sandeep Kumar, and Kavita, and Jyotirmoy Maity, and Ashok K Prasad
January 2013, Bioorganicheskaia khimiia,
Harbansh Singla, and Sandeep Kumar, and Kavita, and Jyotirmoy Maity, and Ashok K Prasad
August 2005, The Journal of organic chemistry,
Harbansh Singla, and Sandeep Kumar, and Kavita, and Jyotirmoy Maity, and Ashok K Prasad
April 2000, Nucleosides, nucleotides & nucleic acids,
Harbansh Singla, and Sandeep Kumar, and Kavita, and Jyotirmoy Maity, and Ashok K Prasad
January 1990, Pharmacology & therapeutics,
Harbansh Singla, and Sandeep Kumar, and Kavita, and Jyotirmoy Maity, and Ashok K Prasad
January 2005, Nucleosides, nucleotides & nucleic acids,
Harbansh Singla, and Sandeep Kumar, and Kavita, and Jyotirmoy Maity, and Ashok K Prasad
June 2018, Acta chimica Slovenica,
Harbansh Singla, and Sandeep Kumar, and Kavita, and Jyotirmoy Maity, and Ashok K Prasad
January 1975, Journal of the Chemical Society. Perkin transactions 1,
Copied contents to your clipboard!